Cann Group in multimillion-dollar cap raise to fund Mildura production growth by Steve Jones June 15, 2023April 30, 2024 Cann Group has returned to shareholders to raise almost A$12 million as it seeks to “realise […]
ANTG subsidiary fined for alleged security ‘failures’ at cultivation site by Steve Jones June 13, 2023April 30, 2024
BBS Pharmaceuticals to be wound up as focus turns to recovering A$3.5m from possible ‘voidable transactions’ by Steve Jones June 7, 2023April 30, 2024
Trademark row brews as Cannatrek looks to monopolise ‘T’ branding by Steve Jones June 7, 2023April 30, 2024
Medlab still in limbo as talks continue with ‘interested parties’ by Steve Jones June 7, 2023April 30, 2024
Scrutiny of SAS-B data for psychiatric conditions exposes prescribing ‘disconnect’ by Steve Jones June 7, 2023April 30, 2024
Montu caught in second product dispute over ‘out of stock’ claims by Steve Jones June 7, 2023April 30, 2024
Creso Pharma eyes Australian market as firm seeks GMP licence by Steve Jones June 6, 2023April 30, 2024
‘It all starts with flower’: Tasmanian Botanics takes local road to long-term success by Steve Jones June 5, 2023April 30, 2024
